Ambe, Wilma A.

HRN: 24-03-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/03/2023
11/11/2023
IV
600mg
QID
DM Foot
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: